CUV 0.67% $14.72 clinuvel pharmaceuticals limited

Ann: Syd Capital Markets Briefing Presentation, page-6

  1. 615 Posts.
    lightbulb Created with Sketch. 291
    I don’t see anything different from previous presentations over the last 5 years. The obvious exception is the vitiligo photos ( almost as good as the ones from 2012) and the commencement of the pk adolescent trial committed to in 2017!

    Other highlights; the 6th indication remains unnamed, Dennis wright apparently spoke, 9 patients recruited into cva trial ( at this rate a properly powered trial will take 30 years), high engagement from lady Gaga event ( leading to more confused individuals wondering where the f* the product is). US adolescents get a mention, although pathway not clear. There is probably more stuff there, only gave it a brief read. Still better options for investors out there.
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
(20min delay)
Last
$14.72
Change
-0.100(0.67%)
Mkt cap ! $737.1M
Open High Low Value Volume
$14.80 $14.97 $14.60 $600.3K 40.64K

Buyers (Bids)

No. Vol. Price($)
2 324 $14.69
 

Sellers (Offers)

Price($) Vol. No.
$14.75 100 1
View Market Depth
Last trade - 16.10pm 06/09/2024 (20 minute delay) ?
CUV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.